Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd.

Division of Novartis AG
www.ty-pharm.com

Latest From Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd.

China’s Best Shot: GSK, Novartis Gear Up For Vaccine Prime Time

With its large population, one-child policy and increasing emphasis on preventative care, China is poised for a vaccine boom. The catalyst for growth may come from the expected modernization of the country’s massive national immunization program.

BioPharmaceutical China

China Compulsory Licensing Reg Opens Door For Generics Of Patented Drugs

Taking the lead from India’s recent compulsory license for Bayer’s Nexavar, China passes a compulsory license regulation that could allow generics on patented drugs.

BioPharmaceutical China

China Compulsory Licensing Reg Opens Door For Generics Of Patented Drugs

Taking the lead from India’s recent compulsory license for Bayer’s Nexavar, China passes a compulsory license regulation that could allow generics on patented drugs.

BioPharmaceutical China

Nestle To Become No. 1 In China's Infant Formula Market Following Pfizer Nutrition Acquisition

With roughly 60% of Pfizer Nutrition sales coming from Asia, and 47% of that from China, Nestle slips into No. 1 spot in China’s infant formula market.

Consumer China
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Novartis AG
  • Senior Management
  • Ding Xiaohang, Chmn. & CEO
  • Contact Info
  • Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd.
    Phone: (86) 571 26286888
    Tianhe Rd. 56
    Linping
    Hangzhou City, PC 311100
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register